These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 18751717)
41. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140 [TBL] [Abstract][Full Text] [Related]
42. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142 [TBL] [Abstract][Full Text] [Related]
43. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. Dada T; Dhawan M; Garg S; Nair S; Mandal S J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079 [TBL] [Abstract][Full Text] [Related]
44. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection. Aggermann T; Stolba U; Brunner S; Binder S Ophthalmologica; 2006; 220(2):131-3. PubMed ID: 16491037 [TBL] [Abstract][Full Text] [Related]
45. Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis. Ganapathy PS; Lowder CY; Arepalli S; Baynes K; Li M; Bena J; Srivastava SK Am J Ophthalmol; 2018 Oct; 194():63-71. PubMed ID: 30053470 [TBL] [Abstract][Full Text] [Related]
46. Fluorescein and indocyanine green angiographic features in acute syphilitic macular placoid chorioretinitis. Baglivo E; Kapetanios A; Safran AB Can J Ophthalmol; 2003 Aug; 38(5):401-5. PubMed ID: 12956283 [No Abstract] [Full Text] [Related]
47. Epiretinal deposit of triamcinolone acetonide at the posterior pole after intravitreal injection. Jaissle GB; Szurman P; Völker M; Bartz-Schmidt KU Ophthalmic Surg Lasers Imaging; 2007; 38(3):238-41. PubMed ID: 17552392 [TBL] [Abstract][Full Text] [Related]
48. Ocular syphilis, a case of acute posterior placoid chorioretinitis. Veys MC; Lafaut B Bull Soc Belge Ophtalmol; 2013; (322):21-5. PubMed ID: 24923078 [TBL] [Abstract][Full Text] [Related]
49. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia. Wu L; Evans T; Arévalo JF; Berrocal MH; Rodríguez FJ; Hsu M; Sánchez JG Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037 [TBL] [Abstract][Full Text] [Related]
50. Retinal break following an intravitreal triamcinolone acetonide injection. Erol N; Topbas S; Sahin A Int Ophthalmol; 2005; 26(4-5):163-5. PubMed ID: 17273904 [TBL] [Abstract][Full Text] [Related]
51. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Patel PJ; Zaheer I; Karia N Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493 [TBL] [Abstract][Full Text] [Related]
52. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
53. Intravitreal and posterior subtenon triamcinolone acetonide for severe acute posterior multifocal placoid pigment epitheliopathy. Vianna RNG; Vanzan V; Turchetti R; Burnier MN Arq Bras Oftalmol; 2019; 82(3):233-235. PubMed ID: 30916213 [TBL] [Abstract][Full Text] [Related]